Moirai Biodesign’s General Shareholders Meeting will be held on June, 28th, at 10:30h. Please find the agenda here.
More
Founded on the combination of cutting-edge synthetic biology and computational biology, Moirai Biodesign is putting RNA design at the service of biomedicine.
We envision our technologies and expertise as the catalysts of a healthcare ecosystem where rapid and affordable diagnostic methods are an option for all patients worldwide.
Amadís Pagès
Co-Founder and CEO
Ivan Dotu
Co-founder and CTO
Daniel Poglayen
Co-founder and CPDO
Cristina Alsina
Research Scientist
Judit Domingo
Product Developer
Gerard Minuesa
Research Scientist
